BioSpace News Archive

Drug Development

Immuron Enrolls First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)

The Immuron CDI clinical study is a Phase I/II placebo-controlled study focusing on the safety, tolerability, and preliminary efficacy of IMM-529.

January 31, 2018
·
7 min read
Lone Star Bio

PositiveID’s FireflyDX Prototype Detects Flu Types; Chief Science Officer Explains Why Accurate Flu Detection at Point of Care Enables Smart Treatment Decisions in Interview With SmallCapVoice.com

The interview can be heard at https://smallcapvoice.com/blog/1-30-18-smallcapvoice-interview-with-positiveid-corporation-psid.

January 31, 2018
·
4 min read
Med Alliance’s SELUTION First-in-Man Study Achieves Primary Endpoint

Primary endpoint data from the FIM study of SELUTION, Med Alliance’s novel sirolimus-coated balloon, was presented today at the Leipzig Interventional Course by Principal Investigator Professor Thomas Zeller, Universitaets-Herzzentrum, Bad Krozingen, Germany.

January 31, 2018
·
3 min read
Genedata Announces Genedata Screener for Massive Mechanistic Analysis

The new version also delivers new functionality for the analysis of kinetic binding assays for small and large molecules, as well as a host of new automation features.

January 31, 2018
·
4 min read
BioMidwest

Skyline Medical Projects 100 STREAMWAY System Sales in the U.S. in 2018

2018 projection would represent a 10x increase over 2017 sales.

January 31, 2018
·
6 min read
CollPlant Announces ADS Listing on NASDAQ

Trading commenced on Wednesday, January 31, 2018 under the ticker symbol “CLGN”.

January 31, 2018
·
4 min read
LINC 2018: BIOTRONIK Presents Excellent 12-Month Data on More Than 1000 Patients

During a well-attended BIOTRONIK-sponsored symposium chaired by Dr. Jos van den Berg, Professor of Interventional Radiology, Ospedale Regionale di Lugano, Switzerland, panelists demonstrated that reducing metal burden in superficial femoral artery therapy could effectively reduce restenosis rates.

January 31, 2018
·
4 min read
Bio NC

Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018

Shares of company stock are anticipated to begin trading on Nasdaq with new ticker INNT and will reflect a 1 for 10 reverse split on Thursday, February 1, 2018.

January 31, 2018
·
4 min read
Business

Lilly Exploring Strategic Alternatives for Animal Health Biz

Sluggish growth is the main driver for the decision..

January 31, 2018
·
50 min read
Business

Seattle Genetics Announces Proposed Public Offering of $550 Million of Shares of Its Common Stock

All of the shares are being offered by Seattle Genetics.

January 31, 2018
·
3 min read